Ver el código de «Patiromer»

==Background==
A potassium binding polymer that unlike [[Kayexylate]] has not been reported to increase the risk of intestinal necrosis. 
==Administration==
*Type: oral powder for suspension 

*Dosage Forms:
**8.4g/packet
**16.8g/packet
**25.2g/packet
*Routes of Administration:
*Common Trade Names: 

==Adult Dosing==
*8.4 g PO qDay
*May increase or decrease dose as necessary (increments of 8.4 g) not to exceed 25.2 g qDay

==Pediatric Dosing==
Safety not established

==Special Populations==
===[[Drug pregnancy categories|Pregnancy Rating]]===
*

===Lactation risk===
*

===Renal Dosing===
*Adult: no adjustments
*Pediatric: not approved

===Hepatic Dosing===
*Adult: no adjustment
*Pediatric: not approved

==Contraindications==
*Allergy to class/drug

==Adverse Reactions==
===Serious===
*Excessive doses > 50g/d can cause profound hypokalemia

===Common===
*Constipation (7.2%)
*Hypomagnesemia (5.3%)
*Diarrhea (4.8%)
*Nausea (2.3%)
*Abdominal discomfort (2%)
*Flatulence (2%)


==Pharmacology==
*Half-life: 
*Metabolism: non-absorbed polymer
*Excretion: Fecal

==Mechanism of Action==
*Binds and removes (via sorbitol induced bowel movements) potassium from the GI tract==Comments==


==See Also==
*[[Kayexylate]]

==References==
<references/>

[[Category:Pharmacology]]